S

SEngine Precision Medicine

27 employees

SEngine Precision Medicine uses algorithms and 3D organoid technology to develop drugs with more efficacy.

Basic info

Industry

biotechnology research

Sectors

Biotechnology
targeted therapies
robotics
drug development
genetic sequencing
oncology
personalized medicine
Health Care
bioinformatics
precision medicine
genomics
Medical
clinical trials
cancer organoid cultures
cancer
oncologists

Date founded

2015

Funding rounds raised

Total raised

$10M

from 4 investors over 4 rounds

S

SEngine Precision Medicine raised $10M on July 28, 2022

Investors: Alethea Capital Management LLC, Washington Research Foundation and Vincere Capital

S

SEngine Precision Medicine raised $3.1M on May 2, 2018

Investors: National Institutes of Health

FAQ